chr11-77103064-G-A
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP7BA1
The NM_006189.1(OMP):c.225G>A(p.Pro75Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.21 in 1,613,472 control chromosomes in the GnomAD database, including 36,614 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_006189.1 synonymous
Scores
Clinical Significance
Conservation
Publications
- CAPN5-related vitreoretinopathyInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae)
- autosomal dominant neovascular inflammatory vitreoretinopathyInheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| OMP | NM_006189.1 | c.225G>A | p.Pro75Pro | synonymous_variant | Exon 1 of 1 | ENST00000529803.1 | NP_006180.1 | |
| CAPN5 | NM_004055.5 | c.297+9251G>A | intron_variant | Intron 3 of 12 | ENST00000648180.1 | NP_004046.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.207 AC: 31523AN: 152058Hom.: 3409 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.218 AC: 54044AN: 248082 AF XY: 0.222 show subpopulations
GnomAD4 exome AF: 0.211 AC: 307650AN: 1461294Hom.: 33198 Cov.: 37 AF XY: 0.213 AC XY: 154799AN XY: 726926 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.207 AC: 31556AN: 152178Hom.: 3416 Cov.: 33 AF XY: 0.211 AC XY: 15673AN XY: 74380 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at